X0508 4 2024-07-01 0000310142 SENSIENT TECHNOLOGIES CORP SXT 0002028258 Vanderleest Adam 777 E. WISCONSIN AVE. MILWAUKEE WI 53202 1 VP, Controller, and CAO 0 Common Stock 2024-07-01 4 A 0 190 0 A 1203 D Common Stock 301.537 I ESOP Performance Stock Unit 2024-07-01 4 A 0 286 0 A Common Stock 286 286 D Represents a grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated, in connection with Mr. Vanderleest's appointment to his new position. The shares are restricted until December 2026 and will vest at the same time and on the same terms as the restricted stock awards granted to the Company's executive officers in December 2023. Represents shares held in Issuer's ESOP as of the end of the month immediately preceding this filing. Each performance stock unit represents a contingent right to receive one share of Issuer's Common Stock. Represents grant of performance stock units under Issuer's 2017 Stock Plan, as amended and restated, in connection with Mr. Vanderleest's appointment to his new position. The terms of this award are the same as the performance stock unit awards granted to the Company's executive officers in December 2023. Represents grant of performance stock units under Issuer's 2017 Stock Plan, as amended and restated. The award is eligible to vest following a three-year performance period (from January 1, 2024 through December 31, 2026) as follows: (1) 70% of the award is eligible to vest upon achievement of certain performance criteria based on EBITDA growth, and (2) 30% of the award is eligible to vest upon achievement of certain performance criteria based on return on invested capital. Subject to certain continued employment conditions and subject to accelerated vesting in certain circumstances, the actual number of shares earned will be determined and vest following the three-year performance period. The number of shares reflected is at the target award amount. No performance stock units will vest below a minimum level of performance. At or above the minimum level of performance, the actual number of shares earned may range from 0% to 200% of the target award amount. /s/ John J. Manning, Attorney-in-Fact for Mr. Vanderleest 2024-07-03